|
|
|
Volumn 5, Issue 3, 2002, Pages 203-205
|
|
Phage Display Technologies - SMi Conference 23-24 January 2002, London, UK
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
AUTOVAC;
BERTILIMUMAB;
BUNGAROTOXIN;
CAMPTOTHECIN;
CYTOKINE;
CYTOTOXIC T LYMPHOCYTE A4 ANTIBODY;
DNA;
EOTAXIN;
EPIDERMAL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GREEN FLUORESCENT PROTEIN;
HER2 CANCER ANTIBODY VACCINE;
INTERLEUKIN 5 DNA VACCINE;
IPILIMUMAB;
MEMBRANE COFACTOR PROTEIN;
MESSENGER RNA;
OSTEOCLAST DIFFERENTIATION FACTOR;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;
T LYMPHOCYTE ANTIBODY;
THROMBIN ANTITHROMBIN COMPLEX;
TUMOR MARKER;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY VACCINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UREA;
VACCINE;
VITRONECTIN;
VN 18;
ADVANCED CANCER;
ALGORITHM;
AMINO ACID SUBSTITUTION;
ANTIBODY ENGINEERING;
ANTIBODY LIBRARY;
ANTIBODY SPECIFICITY;
ANTIBODY TITER;
ARTHRITIS;
B LYMPHOCYTE;
BACTERIOPHAGE M13;
BACTERIOPHAGE T3;
BACTERIOPHAGE T7;
BIOTECHNOLOGICAL PROCEDURES;
CARBOXY TERMINAL SEQUENCE;
CHROMATOPHORE;
CLINICAL TRIAL;
COMPLEMENTARITY DETERMINING REGION;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG POTENCY;
FLUORESCENCE ACTIVATED CELL SORTING;
GENE;
GENE TARGETING;
GENOME;
HUMAN;
HYBRIDIZATION;
IMMUNOTHERAPY;
IN VIVO STUDY;
LASER;
MELANOMA;
MOLECULE;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PROTEIN BINDING;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RECEPTOR BINDING;
RIBOSOME;
|
|
EID: 0141672225
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
